icon
Go back to News
NEWS

GA_P advises ATRYS in its capital increase for the acquisition of Initia and ChileRad

icon 28 of December, 2022
Gómez-Acebo & Pombo advised Atrys Health on the €10.5 million capital increase, by means of cash contributions and exclusion of pre-emptive subscription rights, carried out after a private placement negotiation process, which was aimed at a limited number of qualified investors.

The funds obtained from the capital increase allow the company to undertake the acquisition of Grupo Initia (leader in oncology and clinical trials in Spain) for 2.2 million euros, as well as the acquisition of ChileRad (Telmed and Prestaciones Médicas e Inversiones Chaxa, a telemedicine company specialising in teleradiology services) for a total of 8 million euros, thus consolidating ATRYS’ position in Chile as a leading company in the provision of teleradiology diagnostic services.

The GA_P team was formed by: Guillermo Guerra, Jacobo Palanca and Emiliano Moreno, partner and associates of Coporate and Commercial.

Read the full news.

Autor/s

Guillermo Guerra – Partner

Jacobo Palanca – Senior Associate

See all authorsicon
See fewer authorsicon
Tipology

Deal

Areas and sectors

Corporate and M&A

Press contact

Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
Sandra Cuesta
Sandra Cuesta
Director of Business Development, Marketing and Communications
icon
icon

More information about
Gómez-Acebo & Pombo

icon
icon
icon
icon